In the News

Screening for diabetes may not reduce mortality

One round of screening for type 2 diabetes in high-risk patients was not associated with a reduction in all-cause, cardiovascular, or diabetes-related mortality within 10 years, researchers in the U.K. reported.

Task force releases new standards for diabetes self-management education, support

A task force from the American Diabetes Association (ADA) and American Association of Diabetes Educators (AADE) has released new standards for diabetes self-management education and support.

Physician empathy associated with outcomes for diabetes patients

Diabetes patients who have highly empathic primary care doctors have better clinical outcomes than those whose doctors are less empathic, a new study found.

MKSAP Quiz: inpatient glycemic control

This month's quiz asks readers to evaluate a 78-year-old man with poor glycemic control admitted for femoral-popliteal bypass surgery.

EHRs may improve diabetes management and achievement of treatment goals, particularly among those with worst disease control

Use of a commercially available electronic health record (EHR) was associated with improved care processes and better achievement of intermediate treatment outcomes for outpatients with diabetes, a study found.

Moderate or severe hypoglycemia associated with mortality risk in the ICU

Moderate or severe hypoglycemia in the intensive care unit (ICU) was significantly associated with mortality, according to a new analysis of the NICE-SUGAR trial.

Telemonitoring was associated with greater mortality and did not reduce hospitalizations or ED visits in high-risk elderly patients

A trial in four Minnesota primary care clinics randomized high-risk elderly patients to home telemonitoring or usual care.

Neither n-3 fatty acid supplements nor glargine reduced CV events in patients with dysglycemia

The Outcome Reduction with an Initial Glargine Intervention trial randomized about 12,000 patients with cardiovascular risk factors and dysglycemia to basal insulin glargine or usual care and daily n-3 fatty acid supplementation or olive oil placebo.

Admitting a patient with diabetes to the hospital

Persons with diabetes have a two- to four-fold higher hospitalization rate than do those without diabetes. Pre-established goals and a good admission history can improve their care.

Another weight loss drug approved

A combination of phentermine and topiramate extended-release (Qsymia) was recently approved by the FDA as an addition to a reduced-calorie diet and exercise for chronic weight management.

Spotlight on the state of diabetes

From the ancient Egyptians to current pilot projects, two recent articles in the New England Journal of Medicine reviewed the history and current state of diabetes care.

Global diabetes summit to be held

The 2012 Global Diabetes Summit will be held Nov. 14-17, 2012, in Columbus, Ohio.